Skip to main content
Premium Trial:

Request an Annual Quote

Frank Douglas

Premium

Frank Douglas has been appointed to fill a vacancy on the board of directors of Gene Logic with a term ending at the next annual stockholders meeting, at which time he will be considered for election for a full term. Douglas recently retired from Aventis, where he served as executive vice president of drug innovation and approval and CSO.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more